The doctor says everyone should take GLP-1-by-day medication for optimal health

They may have gained popularity for diabetes and weight loss, but GLP-1 drugs like Ozempic and Wegovy have been linked to constantly expanding health benefits.

In fact, some doctors – including Dr. Terry Dubrow, a plastic surgeon and a television personality based in Newport Beach, California – recommend that everyone takes a low daily dose, even if they don’t need to lose weight.

Dubrow spoke to the camera with Fox News Digital of the advantages of “microdosage” these drugs. (See the video at the top of this article.)

How do GLP-1 work

GLP-1 receptor agonists work by imitating a hormone called glucagon-like peptide-1, which is released from the intestine after eating.

Drugs help regulate blood sugar, slow down stomach emptying and decrease appetite, and it has also been shown to reduce the risk of heart disease.

Dr. Terry Dubrow, plastic surgeon and television personality based in Newport Beach, California, recommends that everyone will take a low daily dose of a GLP-1, even if they do not need to lose weight. (Terry Dubrow)

“Sugar is the enemy, and these drugs affect sugar in your blood,” Dubrow told Fox News Digital. “They affect the way insulin reacts.”

The GLP-1 helps insulin to move glucose (sugar) out of blood circulation and in body cells, where it can be used for energy or stored, said the doctor. Drugs also help prevent inflammation and damage caused by sugar in blood vessels, nerves and organs.

“ Next Ozempic ‘aims to provide weight loss of 30% with fewer side effects

“I do not think that anyone who says that if there was a way to manipulate the amount of sugar and inflammation to which your body is exposed, it is something to which we want to rely. And that’s exactly what these drugs do,” added Dubrow.

In addition to regulating blood sugar and triggering weight loss, GLP-1 have also been approved to reduce the risk of cardiovascular and kidney disease in some patients.

“I have never seen a medicine in the history of medicine on such a fast path to approval.”

“Even if you are not overweight, to be on these drugs GLP-1 … helps to minimize and prevent a repeated recurring heart attack,” said Dubrow.

The semaglutide has also been recently approved for puree (steatohepatitis associated with metabolic dysfunction), an inflammatory form of hepatic steatosis.

Dr. Terry Dubrow and his wife, Real Housewives of Orange County, Heather Dubrow, were seen on August 29, 2024 in Los Angeles, California. (Getty Images)

GLP-1s are also being studied for potential cognitive advantages in Parkinson patients.

“I have never seen a drug in the history of medicine on such a fast path to approval,” said Dubrow.

The microdosage case

With other experts, Dubrow is a microdosage defender, where people take weak and regular doses of GLP-1 every day, even if they do not need it for diabetes or obesity.

While patients with diabetes take doses that are increasing every four weeks, microdosage involves using a low level dose that does not happen.

More difficult weight loss with ultra -processed foods that hide in almost all meals, say experts

A younger population on Tiktok has zero in the microdosage, underlined Dubrow – and he thinks that everyone should do it.

“I am obsessed with the concept of microdosage,” he said. “I think that perhaps half of the starting dose for diabetes is the way to follow – and you probably don’t need it every seven days, it’s probably every 10 days, just to adjust the amount of blood sugar.”

“Even if you are not overweight, to be on these drugs GLP-1 … helps to minimize and prevent a repeated recurring heart attack,” said Dubrow. (istock)

The doctor noted that there were still a lot of unknowns with GLP-1 drugs.

“We now determine how to use these drugs for various indications, for various reasons,” he said. “We learn as we use.”

“I am obsessed with the concept of microdosage.”

As with other drugs, such as Botox, Dubrow said that there was a little “human experiment” at stake.

“We understand it, and we teach the medical profession how to do it. Patients tell us how to use these drugs.”

Potential risks

GLP-1 drugs have been linked to several potential risks. The most widespread is gastrointestinal problems, such as nausea and vomiting.

Others have reported an increased risk of pancreatitis, muscle loss and thyroid tumors.

“I have read all the studies that come out on these drugs, and I can tell you, it is very clear that they do not cause pancreatitas,” said Dubrow.

Ozempic dust for the elderly? Some doctors say that more people aged 65 and over should be there

“In fact, if you really look at the people who use it, pancreatitis is less in these populations.”

Dubrow confirmed, however, that the drug had been linked to an increased risk of very rare spinal cord cancer of the thyroid.

Those who experience serious side effects from GLP-1 should speak to a doctor, Dubrow said. (istock)

“If you have family history, it is a contraindication to use these drugs for you,” he said.

Regarding the digestive side effects, the doctor said that the drugs slowed down the gastrointestinal tract, but it has been shown that the body adapts to this over time.

“These special drugs are natural hormones that occur in our small intestine, and you get used to side effects. They disappear.”

Click here to obtain the Fox News app

The severity of the side effects is linked to the dose amount, noted Dubrow.

“The low dose, in particular microdosis, really has a low propensity for constipation, nausea, potential diarrhea, RGC (reflux),” he said. “I think these side effects are less important for people who microdose.”

To counter the risk of muscle loss, Dubrow recommends increasing protein intake and incorporating resistance drive as a central component of an exercise routine.

Those who experience serious side effects should speak to a doctor, he advised.

The out -of -MA of GLP -1 use, as for microdosage, is common, said Dubrow – “but finding a doctor willing to prescribe can be difficult.” (istock)

Drug manufacturers weigh

When contacted by Fox News Digital, the manufacturers of GLP-1 medication warned against the microdosage of products.

“Lilly has no data on the advantages or risk of microdosage of Zepbound and Mounjaro,” said a spokesperson for Eli Lilly, manufacturer of GLP-1 medications Mounjaro and Zepbounda. “Self -injectors and ZEPBOUND bottles are only approved by single use – the dose or the” microdosage “is not envisaged by the FDA label. As such, the out -of -label use of Zepbound and Mounjaro may present patient safety risks.”

“Use outside the Amme de Zepbounde and Mounjaro may present patient safety risks.”

Novo Nordisk, manufacturer of Ozempic and Wegovy, said that he did not tolerate “mistreatment” of his products.

“It is important to understand that for Wegovy, only the doses marked on single-use dose pens (0.25, 0.5, 1.0, 1.7 and 2.4 mg) are approved for use and represent an authentic drug approved by the FDA,” said a spokesperson for Fox News. “Wegovy®’s starting dose is 0.25 mg once a week, and the dose will gradually increase every four weeks. Patients should work with their health professional to select 1.7 mg or 2.4 mg for the maintenance dose.”

Cheap ozempic slaughter have increased in popularity

“It is also important to note that the authentic Wegovy’s injectable pen is designed as a single -use pen, the dose is already defined and must not be modified or falsified and the pen must be eliminated after use.”

“Ozempic is a multi-purpose pen with a pen and several needles,” added the spokesperson.

Access GLP-1

Dubrow said he was not concerned about supply problems in the growing popularity of GLP-1, because large pharmaceutical companies have the resources to “increase” to meet demand.

The out -of -MA of GLP -1 use, as for microdosage, is common, said Dubrow – “but finding a doctor willing to prescribe can be difficult.”

Click here to register for our Health Newsletter

The doctor warned against the purchase of these drugs on online markets, which he described as “Wild Wild West”.

“It is difficult to find these drugs online from aggravating pharmacies, because essentially they become thugs-it is illegal. They do not allow it to do so,” he warned.

“These drugs are natural hormones that occur in our small intestine, and you get used to side effects.”

“So, if you get it from rogue pharmacies that are not allowed to do it or you are ready to fold the rules, what is it? You don’t know what you get.”

“It can be a strange and strange version that has side effects or that is not effective.”

Ahead

There are several new generation drugs in development that combine several hormonal paths, said Dubrow.

“I predict within five years, we will have a pill … designed to manipulate hunger and resistance to insulin,” he predicted.

For more health items, visit www.foxnews.com/health

Overall, Dubrow said that GLP-1 are “here to stay”.

“They will just improve, and we will learn to use them in a more appropriate and clinically effective way,” he said. “So tie your seat belt. If you’re not on them now, you will be later.”